China SXT Pharmaceuticals, Inc. Cash and Cash Equivalents, Period Increase (Decrease)
China SXT Pharmaceuticals, Inc. (SXTC) reported Cash and Cash Equivalents, Period Increase (Decrease) of $6.07 million for the 12-month period ending 2021-03-31, per its 20-F filed 2021-08-13.
Discontinued › Cash Flow › Change in Cash
us-gaap:CashAndCashEquivalentsPeriodIncreaseDecrease · last filed 2021-08-13
| Period end | Cash and Cash Equivalents, Period Increase (Decrease) 6 month | Cash and Cash Equivalents, Period Increase (Decrease) 12 month |
|---|---|---|
| 2021-03-31 | $6.07M 20-F · filed 2021-08-13 | |
| 2020-03-31 | -$2.00M 20-F · filed 2021-08-13 | |
| 2019-09-30 | -$967.71K 6-K/A · filed 2020-05-22 | |
| 2019-03-31 | $8.63M 20-F · filed 2021-08-13 | |
| 2018-09-30 | -$194.37K 6-K/A · filed 2020-05-22 | |
| 2018-03-31 | $592.20K 20-F · filed 2020-07-31 | |
| 2017-03-31 | $54.13K 20-F · filed 2019-08-15 |